Arrhythmias in primary hyperparathyroidism evaluated by exercise test

European Journal of Clinical Investigation

Volumn 43, Issue 2, 2013, Pages 208-214

  Pepe, Jessica ^a   Curione, Mario ^a   Morelli, Sergio ^a   Colotto, Marco ^a   Varrenti, Marisa ^a   Castro, Claudia ^a   D'Angelo, Antonella ^a   Cipriani, Cristiana ^a   Piemonte, Sara ^a   Romagnoli, Elisabetta ^a   Minisola, Salvatore ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Arrhythmias risk factors; Bicycle ergometer exercise test; Primary hyperparathyroidism; QT interval; Ventricular premature beats

Indexed keywords

25 HYDROXYVITAMIN D; CALCIUM; CREATININE; MAGNESIUM; PARATHYROID HORMONE; PHOSPHORUS; POTASSIUM;

ADULT; AGED; ARTICLE; BICYCLE ERGOMETRY; CALCIUM BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; ECHOCARDIOGRAPHY; EXERCISE TEST; FEMALE; HEART VENTRICLE EXTRASYSTOLE; HUMAN; MINERAL METABOLISM; POSTMENOPAUSE; PRIMARY HYPERPARATHYROIDISM; PRIORITY JOURNAL; QT INTERVAL;

AGED; ARRHYTHMIAS, CARDIAC; CALCIUM; CASE-CONTROL STUDIES; ELECTROCARDIOGRAPHY; EXERCISE; EXERCISE TEST; FEMALE; HEART RATE; HUMANS; HYPERPARATHYROIDISM, PRIMARY; MIDDLE AGED; POSTMENOPAUSE; RISK FACTORS;

EID: 84872615261     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/eci.12038     Document Type: Article

References (33)

1. Surawicz B. Relationship between electrocardiogram and electrolytes. Am Heart J 1967;73:814-34.
2. Stefenelli T, Wikman-Coffelt J, Wu ST, Parmley WW. Calcium-dependent fluorescence transients during ventricular fibrillation. Am Heart J 1990;120:590-7.
3. Kiewiet RM, Ponssen HH, Janssens EN, Fels PW. Ventricular fibrillation in hypercalcaemic crisis due to primary hyperparathyroidism. Neth J Med 2004;62:94-6.
4. Vestergaard P, Mollerup CL, Frøkjaer VG, Christiansen P, Blichert-Toft M, Mosekilde L. Cardiovascular events before and after surgery for primary hyperparathyroidism. World J Surg 2003;27:216-22.
5. Hedbäck G, Odén A. Increased risk of death from primary hyperparathyroidism-an update. Eur J Clin Invest 1998;4:271-6.
6. Chang CJ, Chen SA, Tai CT, Yu WC, Chen YJ, Tsai CF et al. Ventricular tachycardia in a patient with primary hyperparathyroidism. Pacing Clin Electrophysiol 2000;23:534-7.
7. Lind L, Ljunghall S. Serum calcium and the ECG in patients with primary hyperparathyroidism. J Electrocardiol 1994;27:99-103.
8. Zhang Y, Post WS, Dalal D Bansal S, Blasco-Colmenares E, Jan De Beur S et al. Serum 25-hydroxyvitamin D, calcium, phosphorus, and electrocardiographic QT interval duration: findings from NHANES III and ARIC. J Clin Endocrinol Metab 2011;96:1873-82.
9. Saikawa T, Tsumabuki S, Nakagawa M, Takakura T, Tamura M, Maeda T et al. QT intervals as an index of high serum calcium in hypercalcemia. Clin Cardiol 1988;11:75-8.
10. ZhangY, Post WS, Dalal D, Blasco-Colmenares E, Tomaselli GF, Guallar E. QT-interval duration and mortality rate: results from the Third National Health and Nutrition Examination Survey. Arch Intern Med 2011;171:1727-33.
11. Vandenbroucke JP, von Elm E, Altman DG, Gøtzsche PC, Mulrow CD, Pocock SJ et al. Strengthening the reporting of observational studies in epidemiology (STROBE): explanation and elaboration. PLoS Med 2007;4:e297.
12. Simera I, Moher D, Hoey J, Schulz KF, Altman DG. A catalogue of reporting guidelines for health research. Eur J Clin Invest 2010;40:35-53.
13. Maggio D, Cherubini A, Lauretani F, Russo RC, Bartali B, Piereandrei M et al. 25(OH)D serum levels decline with age earlier in women than in men and less efficiently prevent compensatory hyperparathyroidism in older adults. J Gerontol A Biol Sci Med Sci 2005;60:1414-9.
14. Pepe J, Petrucci MT, Nofroni I, Fassino V, Diacinti D, Romagnoli E et al. Lumbar bone mineral density as the major factor determining increased prevalence of vertebral fractures in monoclonal gammopathy of undetermined significance. Br J Haematol 2006;134:485-90.
15. Carnevale V, Dionisi S, Nofroni I, Romagnoli E, Paglia F, De Geronimo S et al. Potential clinical utility of a new IRMA for parathyroid hormone in postmenopausal patients with primary hyperparathyroidism. Clin Chem 2004;50:626-31.
16. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976;16:31-41.
17. Caldwell G, Kellett HA, Gow SM, Beckett GJ, Sweeting VM, Seth J et al. A new strategy for thyroid function testing. Lancet 1985;1:1117-9.
18. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005;18:1440-63.
19. Gibbons RJ, Balady GJ, Bricker JT, Chaitman BR, Fletcher GF, Froelicher VF et al. ACC/AHA 2002 guideline update for exercise testing: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1997 Exercise Testing Guidelines). Circulation 2002;106:1883-92.
20. Malfatto G, Zaza A, Facchini M. Different effects of antiarrhythmic drugs on the rate-dependency of QT interval: a study with amiodarone and flecainide. J Cardiovasc Pharmacol 2007;50:535-40.
21. Bazzet HD. An analysis of the time relations of electrocardiograms. Heart 1920;7:353-70.
22. Nishime EO, Cole CR, Blackstone EH, Pashkow FJ, Lauer MS. Heart rate recovery and treadmill exercise score as predictors of mortality in patients referred for exercise ECG. JAMA 2000;284:1392-8.
23. Cole CR, Blackstone EH, Pashkow FJ, Snader CE, Lauer MS. Heart-rate recovery immediately after exercise as a predictor of mortality. N Engl J Med 1999;341:1351-7.
24. Bilezikian JP, Khan AA, Potts JT Jr on behalf of the Third International Workshop on the Management of Asymptomatic Primary Hyperthyroidism. Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the Third International Workshop. J Clin Endocrinol Metab 2009;94:335-9.
25. Nilsson IL, Aberg J, Rastad J, Lind L. Left ventricular systolic and diastolic function and exercise testing in primary hyperparathyroidism - effects of parathyroidectomy. Surgery 2000;128:895-902.
26. El-Sherif N, Turitto G. Electrolyte disorders and arrhythmogenesis. Cardiol J 2011;18:233-45.
27. + exchanger function underlie delayed afterdepolarizations in patients with chronic atrial fibrillation. Circulation 2012;125:2059-70.
28. Antzelevitch C, Pollevick GD, Cordeiro JM, Casis O, Sanguinetti MC, Aizawa Y et al. Loss-of-function mutations in the cardiac calcium channel underlie a new clinical entity characterized by ST-segment elevation, short QT intervals, and sudden cardiac death. Circulation 2007;115:442-9.
29. Nattel S, Dobrev D. The multidimensional role of calcium in atrial fibrillation pathophysiology: mechanistic insights and therapeutic opportunities. Eur Heart J 2012;33:1870-7.
30. Curione M, Amato S, Di Bona S, Petramala L, Cotesta D, Letizia C. Parathyroidectomy erase increased myocardial electrical vulnerability in patients with primary hyperparathyroidism. Int J Cardiol 2010;141:201-2.
31. Curione M, Letizia C, Amato S, Di Bona S, Di Fazio F, Minisola S et al. Increased risk of cardiac death in primary hyperparathyroidism: what is a role of electrical instability? Int J Cardiol 2007;121:200-2.
32. Giustetto C, Di Monte F, Wolpert C, Borggrefe M, Schimpf R, Sbragia P et al. Short QT syndrome: clinical findings and diagnostic-therapeutic implications. Eur Heart J 2006;27:2440-7.
33. Johnson NP, Holly TA, Goldberger JJ. QT dynamics early after exercise as a predictor of mortality. Heart Rhythm 2010;7:1077-84.